Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Target |
Action inhibitors |
Mechanism PDGFRα inhibitors(Platelet-derived growth factor receptor alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 11 May 2023 | |
Cardiovascular Diseases | Discovery | - | 11 May 2023 | |
Gastrointestinal Diseases | Discovery | - | 11 May 2023 | |
Gastrointestinal Diseases | Discovery | - | 11 May 2023 | |
Neoplasms | Discovery | - | 11 May 2023 | |
Neoplasms | Discovery | - | 11 May 2023 | |
Nervous System Diseases | Discovery | - | 11 May 2023 | |
Nervous System Diseases | Discovery | - | 11 May 2023 | |
Other Diseases | Discovery | - | 11 May 2023 | |
Other Diseases | Discovery | - | 11 May 2023 |